| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/25/2010 | CA2757838A1 Synthetic endoxifen for treating mammalian diseases |
| 11/25/2010 | CA2752550A1 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione |
| 11/24/2010 | EP2253698A1 Microemulsion |
| 11/24/2010 | EP2253697A1 Method for expanding the temperature range in microemulsions using additives |
| 11/24/2010 | EP2253665A1 Freeze-dried composition |
| 11/24/2010 | EP2253612A1 Organic compounds |
| 11/24/2010 | EP2253326A1 Pharmaceutical composition for transnasal administration |
| 11/24/2010 | EP2253325A1 Agent for enhancing corneal epithelial barrier function |
| 11/24/2010 | EP2253322A1 Method and composition containing latanoprost for treating ocular hypertension and glaucoma |
| 11/24/2010 | EP2253318A1 Improvement of dissolvability of preparation containing olmesartan medoxomil |
| 11/24/2010 | EP2253312A2 Use of osmolytes obtained from extremophilic bacteria for the preparation of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device containing osmolytes as active agents |
| 11/24/2010 | EP2253310A1 Sustained release pharmaceutical formulation comprising phenylephrine |
| 11/24/2010 | EP2253309A2 Gastric acid secretion inhibiting composition |
| 11/24/2010 | EP2253308A1 Pharmaceutical composition comprising microbubbles for targeted tumor therapy |
| 11/24/2010 | EP2253307A1 L-Carnitin for supression of crystallisation |
| 11/24/2010 | EP2253306A1 Orodispersible dosage forms containing solid drug dispersions |
| 11/24/2010 | EP2253224A1 Ondansetron film compositions |
| 11/24/2010 | EP2252323A2 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 11/24/2010 | EP2252304A2 Platinum aggregates and process for producing the same |
| 11/24/2010 | EP2252292A2 Cardioplegia solution for cardiac surgery |
| 11/24/2010 | EP2252290A1 Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
| 11/24/2010 | EP2252284A1 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability |
| 11/24/2010 | EP2252281A2 Blood substitute solution |
| 11/24/2010 | EP2252275A2 Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
| 11/24/2010 | EP2252273A1 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
| 11/24/2010 | EP2252272A2 Gingival wafer |
| 11/24/2010 | EP2252271A2 Dip coated compositions containing a starch having a high amylose content |
| 11/24/2010 | EP2252270A2 Formulations of flibanserin |
| 11/24/2010 | EP2252269A1 Casein particles encapsulating therapeutically active agents and uses thereof |
| 11/24/2010 | EP2252268A1 Pulmonary formulations of triptans |
| 11/24/2010 | EP2252267A2 Lyophilized nanoemulsion |
| 11/24/2010 | EP2252266A1 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents |
| 11/24/2010 | EP2252265A2 Injectable preparations and a process of preparation thereof |
| 11/24/2010 | EP2252264A1 Injectable biocompatible composition |
| 11/24/2010 | EP2252263A1 Galenic form for the oral transmucosal delivery of triptans |
| 11/24/2010 | EP2252262A1 Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol |
| 11/24/2010 | EP2252261A2 Drug delivery system with stabilising effect |
| 11/24/2010 | EP2252260A2 Method for stabilization of s-nitrosoglutathione and composition prepared by the same |
| 11/24/2010 | EP2252259A2 Parenteral formulations of dopamine agonists |
| 11/24/2010 | EP2252254A2 Compositions and devices |
| 11/24/2010 | EP2063868B1 Pharmaceutical compositions containing rosuvastatin calcium |
| 11/24/2010 | EP1970055B1 Multi-layered tablet with triple release combination |
| 11/24/2010 | EP1940353B1 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 11/24/2010 | EP1865971B1 Lubricating composition |
| 11/24/2010 | EP1799191B1 Modifying surfaces of lactose serving as an auxiliary agent to be used for powder inhalants |
| 11/24/2010 | EP1773253B1 Spinal disc nucleus pulposus implant |
| 11/24/2010 | EP1758588B1 Pharmaceutical composition comprising an ointment and two solubilized active principles |
| 11/24/2010 | EP1714653B1 Aqueous solution preparation containing a camptothecin |
| 11/24/2010 | EP1641462B1 Enteric coated composition comprising prostaglandin analogs as chloride channel opener |
| 11/24/2010 | EP1562585B1 Daily melatonin dosing units |
| 11/24/2010 | EP1434840B1 Low-viscosity opacifiers free from anionic surface-active agents |
| 11/24/2010 | EP1385948B1 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 11/24/2010 | EP1175200B1 Use of nanoscalar antimicrobial active ingredients in body deodorants |
| 11/24/2010 | EP0891186B1 Nasal administration of agents for treatment of delayed onset emesis |
| 11/24/2010 | CN201642995U Bone knitting pill |
| 11/24/2010 | CN201642994U Traditional Chinese medicine paste for dysmenorrhea |
| 11/24/2010 | CN201642993U Patch |
| 11/24/2010 | CN201642992U Acne removing plaster |
| 11/24/2010 | CN201642991U Rectangular western medicine tablet |
| 11/24/2010 | CN1973852B Medicine composition containing matrine and astragaloside and its use |
| 11/24/2010 | CN1969970B Application of Rununculus Sieboldii Miq in preparation of medicament for treating gallbladder disease and gastrointestinal convulsion |
| 11/24/2010 | CN1960705B Therapeutic foam |
| 11/24/2010 | CN1955159B Composite for blocking 5-hydroxytryptamine and norepinephrine reabsorbed, its preparation method and its use |
| 11/24/2010 | CN1947796B Chemical modified adefovir and tynofovir |
| 11/24/2010 | CN1942181B Tablet containing branched chain amino acid and process for producing the same |
| 11/24/2010 | CN1935253B Cerebral proteolysis dispersible tablet and its preparing method |
| 11/24/2010 | CN1929868B Lyposome-containing x ray-imaging agent and method for producing the same |
| 11/24/2010 | CN1927879B Thymopentapeptide active isomer and application thereof in pharmaceutical preparation |
| 11/24/2010 | CN1921896B Haemostatic sprays and compositions |
| 11/24/2010 | CN1903268B Medicine composition for treating atherosclerosis and its prepn. method |
| 11/24/2010 | CN1861087B High purity wild Radix scutellariae glucoside medicine composition, and application of making medicine to treat diseases of cardiovascular and cerebrovascular |
| 11/24/2010 | CN1747738B Sustained release of antifectives |
| 11/24/2010 | CN101896595A Bactericidal cleanser composition |
| 11/24/2010 | CN101896210A Zibotentan composition containing mannitol and/or microcrystalline cellulose |
| 11/24/2010 | CN101896203A Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 11/24/2010 | CN101896179A Tape preparation comprising etodolac in ionic liquid form |
| 11/24/2010 | CN101896175A Loxoprofen-containing aqueous plaster |
| 11/24/2010 | CN101896173A Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same |
| 11/24/2010 | CN101896172A Multi-zone films |
| 11/24/2010 | CN101896171A Water dispersible polymer compositions |
| 11/24/2010 | CN101896170A Water dispersible enteric coating formulation for nutraceutical and pharmaceutical dosage forms |
| 11/24/2010 | CN101896169A Salts of active ingredients with polymeric counter-ions |
| 11/24/2010 | CN101896168A Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release |
| 11/24/2010 | CN101896167A Pharmaceutical compositions |
| 11/24/2010 | CN101896166A Film coated tablets containing drospirenone as active agent and a method for the preparation thereof |
| 11/24/2010 | CN101896165A Organic compounds |
| 11/24/2010 | CN101896164A Process for producing biological ingesta and biological ingesta obtained thereby |
| 11/24/2010 | CN101896163A Antibody formulation |
| 11/24/2010 | CN101896162A Organic compounds |
| 11/24/2010 | CN101896161A Solid formulations of crystalline compounds |
| 11/24/2010 | CN101896160A Cyclosporin compositions |
| 11/24/2010 | CN101896155A Skin external preparation and method of producing the same |
| 11/24/2010 | CN101896147A Micro- and/or nano-structured packaging material |
| 11/24/2010 | CN101892177A Antifungal lipopeptid-containing skin liniment and preparation method thereof |
| 11/24/2010 | CN101891801A Saturated aliphatic chain alcohol RGD (Arginyl-Glycyl-Aspartic acid) pentapeptide diester compound, synthesis method and application thereof |
| 11/24/2010 | CN101891800A Saturated aliphatic chain alcohol RGD pentapeptide ester compound, synthetic method and application thereof |
| 11/24/2010 | CN101891783A Flavone-metal complex microsphere and preparation method and application thereof |
| 11/24/2010 | CN101890181A Swine fibrin glue powder inhalation and preparation method and application thereof |
| 11/24/2010 | CN101890170A Nanostructured lipid carrier, preparation method and application thereof |
| 11/24/2010 | CN101890169A Moxifloxacin oral preparation and preparation method thereof |